A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed. Study design was a 3-month, randomized, blinded, group comparison with eight subjects per group. No placebo comparison was used. All three treatment groups showed significant improvements in attention deficits, impulsivity, oppositional, and conduct disordered symptoms as assessed by parent and teacher rating scales and laboratory measures. Significant differences among treatment groups were found only on a few measures. Only the clonidine monotherapy group showed significantly decreased fine motor speed. These results suggest the safety and efficacy of clonidine alone or in combination with MPH for the treatment of ADHD and aggressive oppositional and conduct disorders.
Get full access to this article
View all access options for this article.
References
1.
1. American Psychiatric Association. Diagnostic ((nd Statistical AlCanal Of iakental Disorders, 4th ed.Washington, DC: American Psychiatric Press; 1994:78-85.
2.
2. American Academx of Child and Adolescent Psxchiatry Work Group on Quality Issues. Practice parameters for the assessment and treatment of children, adolescents, and adults wvith attention-deficit/hx peractix itI disorder. A1ni Acad Child Adolesc Psychiiatri. 1997;36(Suppl 10):85S-121S.
3.
3. Barklev RA. Attention Deficit Hpteriactivity Disorder: A Handbook Joi Dicignosts and Treatinent, 2nd ed.New York: Guilford Press; 1998.
4.
4. Gadows KD, Nolan EE, Sxerd J, et al. MIethxlphenidate in hyperactive bovs: I. Effects on peer aggression in public school settings.J Ani Acad Child Adolesc Pgschinaty. 1990;29:710-718.
5.
5. Hinshawx SP. Stimulant medication and the treatment of aggression in children isith attentional deficits. J C(in Chile! Psychol. 1991;20:301-312.
6.
6. Kaplan SLt, Busner J, Kupietz S, et al. Effects of meth Nlphenidate on adolescents wvith aggressive conduct disorder and ADDH: a preliminary report. J Aiii Acad Child Adolesc Psychilatiny. 1990;29:719-723.
7.
7. Klein RG, Abikoff H, Klass E, et al. Clinical efficacy of methylphenidate in conduct disorder wvith and Wvithout attention deficit hvperactixitx disorder. Aich Gen Ps)xchia-try. 1997;54:1073-1080.
8.
8. Hunt D, Capper L, O'Connell P. Clonidine in child and adolescent ps N chiatry.J Child Adolesc Psychophernincieol. 1990;1:87-102.
9.
9. Hnnt D, Mandl L, Las S, Hughes M. Neurobiological theories of ADHD and Ritalin. In: Greenhill I t I, Osman BB, eds. Rital in: T heor-Y and Paltien t Maiianageiiieiit. Nexw York: Marx Ann Liebert; 1991:267-287.
10.
10. Zametkin IA, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?J Am Acad Child Adolesc Psychiatry. 1987;26:676-686.
11.
11. Steingard RJ, Biederman J, Spencer T, et al. Comparison of clonidine response in the treatment of attention-deficit hyperactiv it disorder with and without comorbid tic disorders. JAm Acad Child Adolesc Psychi altr. 1993; 32:350-353.
12.
12. Kemph JP, DeVane CL, Levin GM, et al. Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiairv. 1993;32:577-581.
13.
13. Gunning B. A controlled trial of clonidine in hyperkinetic children. Published Doctoral Dissertation, Department of Child and Adolescent Psychiatry. Rotterdain, The Netherlands: Academic Hospital; 1992.
14.
14. Hunt D, Minderaa R, Cohen D. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate. Psychopharmacol Bull. 1986;22:229-236.
15.
15. Sssanson JM, Flockhart D, Udrea D, et al (Letter). Clonidine in the treatment of ADHD: questions about safets and efficacy. J Child Adolesc Psyliaphlamacol. 1995;5:301-304.
17. Popper C. Combining methylphenidate and clonidine. Pharmacologic questions and news reports about sudden death. J Child Adolesc Psychopha macol. 1995;5:157-166.
18.
18. American Psychiatric Association. Diagfnostic and Statistihal Manual of Mental Disorders, 3rd ed., resised. Washington, DC: American Psychiatric Press; 1987.
19.
19. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Clinical Workbook. New York: Guilford Press; 1991:5-23.
20.
20. Achenbach TM, Edelbrock C. lfanual fot the Child Behavior Checklist and Revised Child Behavior Profile. Burlington: Unisersits of Vermont Department of Psychiatry; 1983.
21.
21. Edelbrock CS. Child Attention Problems (CAP) rating scale. In: Barkley, RA, ed. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Ness York: Guilford Press; 1990:302-305.
22.
22. Spencer T, Biedertman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc PIechiatry. 1996;35:409-432.
23.
23. Safer DJ. Relatise cardiovascular safety of psychostimulants used to treat attention-deficit hw peractivity disordet. J Child Adolesc Ps'ychopharmacol. 1992;4:279-289.
24.
24. DuPaul GJ. ADHD tating scale. In: Barkley, RA, ed. Attention Deficit Hyperactivity Disordei.: A Handbook for Diagnosis and lreatmenet. New York: Guilford Press; 1990:310-311.
25.
25. DttPaul GJ, Rapport MD, Perriello LM. Teacher ratings of academic skills: the development of the acadeumic performance rating scale. Sch Psychol Rev. 1991;20:284-300.
26.
26. Barkley RA. Attention-Deficit HFperictivity Disorder: A Handbook for Diaguosis and Trieatnient. New York: Guilford Press; 1990.
27.
27. Gordon M. Microprocessot-based assessment of attention deficit disorders. Psychopharimacol Bull. 1986;22: 288-290.
28.
28. Reitan RI, Tolfson D. lie Halstead-Reitan Neuroqpsschological test Battery. Tucson, AZ: Neuropsychological Press; 1985.
29.
29. Hollingshead AB. Four factor index of social status. New Has en, CT: Departmsent of Sociology; Yale University; 1975.
30.
30. Singer HS, Brossn J, Quaskey S, et al. The treatment of attention-deficit hv- peractivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine anti desipramine. Pediatrics. 1995;95:74-81.
31.
31. Weiss G, Hechtman L. Hyperactive Children Growin Upb. New York: Guilford Press; 1986.
32.
32. Victorica BE. Electrocardiogram interpretation and diagnostic salue. In: Gessner IH, Victorica BE, eds. Pediatric Caridiology, A Problem Oriented Appioach. Philadelphia: WB Saunders Co; 1993:50-51.
33.
33. Hoffman BB, Lefkowitz RJ. Catecholamines, syrmpathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Good man & Gilman s Vhe Pharmnacolog ical Basis of lietapeutics, 9th ed.New York: McGraw-Hill; 1996:199-248.
